If you are taking an FAA-approved weight loss medication, you must provide your AME with a current, detailed clinical progress note from your treating healthcare provider
Sources FDA Import Alert 66-80: Detention Without Physical Examination of Drug Products Containing GLP-1 Receptor Agonists and Certain Peptide Drug Products Federal Food, Drug, and Cosmetic Act Section 801 (Imports) FDA Drug Establishments Current Registration Site (DECRS) FDA: Frequently Asked Questions About Drug Shortages FDA Warning Letters Database PeptideKnow: Supply Chain and Enforcement Are the Real Bottlenecks (Apr 22, 2026) Sources & References FDA PCAC Meeting Announcement (July 23-24, 2026) PBS: FDA to Weigh Easing Limits on Peptides Favored by RFK Jr
These metabolic improvements occurred alongside increased phosphorylation of insulin receptor substrate and Akt, key signaling molecules in the insulin/IGF-1 pathway
The protein may interfere with plaque formation that causes Alzheimers
Reduced risk of colorectal cancer A cohort study published in JAMA analyzed colorectal cancer risk in patients with type 2 diabetes with or without obesity and overweight
Ozempic, a type 2 diabetes product without a weight-management indication, has a recommended maintenance dosage of 0.5, 1 or 2 mg once weekly with 2 mg as its labeled maximum
